IUS Publications

Found 8 results
Filters: Author is Lejla Mahmutovic  [Clear All Filters]
2024
A. Hromic-Jahjefendic, Mahmutovic, L., Sezer, A., Becirevic, T., Rubio-Casillas, A., Redwan, E. M., and Uversky, V. N., “The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions”, Cytokine & Growth Factor Reviews, 2024.
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, 2023.
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, 2023.
A. Sezer, Mahmutovic, L., and Akcesme, B., “In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma”, Medical Oncology, 2023.
2022
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.
E. Bilajac, Mahmutovic, L., Lundstrom, K., Glamočloja, U., Šutković, J., Sezer, A., and Hromic-Jahjefendic, A., “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, MDPI Viruses, 2022.
2021
L. Mahmutovic, “Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials”, Microorganisms, vol. 9, 2021.